Core Viewpoint - MoonLake Immunotherapeutics faces a class action lawsuit following disappointing Phase 3 trial results for its drug candidate sonelokimab, which failed to demonstrate efficacy compared to a competitor's product, leading to a significant drop in stock price [2][3]. Company Overview - MoonLake Immunotherapeutics is a biopharmaceutical company focused on developing innovative therapies, particularly in the field of immunotherapy [1]. Legal Proceedings - A class action lawsuit has been filed against MoonLake Immunotherapeutics, with a deadline of December 15, 2025, for shareholders to file a lead plaintiff motion [1][4]. - The lawsuit alleges that the company made materially false and misleading statements regarding its drug candidate sonelokimab and failed to disclose critical information about its efficacy compared to competitors [3]. Financial Impact - Following the announcement of the Phase 3 trial results on September 28, 2025, MoonLake's stock plummeted by $55.74, or 89.9%, closing at $6.24 per share on September 29, 2025, significantly harming investors [2].

Core Viewpoint - Glancy Prongay & Murray LLP has initiated an investigation into James Hardie Industries plc regarding potential violations of federal securities laws affecting investors [1] Company Summary - The investigation is on behalf of investors who may have incurred losses related to James Hardie Industries plc (NYSE: JHX) [1] - The law firm is encouraging affected investors to inquire about pursuing claims to recover their losses [1]

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Stride, Inc. (“Stride” or the “Company”) (NYSE:LRN). The investigation concerns whether the Company may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On September 10, 2025, the Gallup-McKinley County Schools Board of Education announced that it had filed a verified complaint against Stride “charg ...

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the United States and Canada [4]. Allegations and Misrepresentation - During the relevant period, James Hardie claimed that its North American fiber cement segment showed "inherent strength" and "underlying momentum," while in reality, sales were driven by inventory loading by channel partners, indicating fraudulent channel stuffing rather than sustainable customer demand [5]. Stock Performance and Impact - On August 19, 2025, James Hardie reported a 12% decline in North American fiber cement sales, attributed to destocking efforts by customers. Following this announcement, the stock price plummeted by $9.79 per share, a decrease of over 34%, from $28.43 to $18.64 [6].

Core Viewpoint - A class-action lawsuit has been filed against James Hardie Industries plc, alleging securities fraud related to misleading investors about inventory levels and customer demand in its North American segment [1][12]. Summary by Sections Lawsuit Details - The lawsuit, titled Laborers' District Council & Contractors' Pension Fund of Ohio v. James Hardie Industries PLC., was filed on behalf of investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025 [3]. - The lawsuit seeks damages for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [3]. Allegations of Misleading Information - The action focuses on James Hardie's North America Fiber Cement segment, which accounts for approximately 80% of the company's total earnings [4]. - Plaintiffs allege that management denied significant inventory destocking trends observed in April and May 2025, misleading investors about the segment's strength [4][5]. Impact of Allegations - The complaint highlights that company executives made statements around May 20 and 21, 2025, falsely claiming robust customer demand and denying inventory destocking [5]. - The lawsuit claims that sales were artificially inflated due to "inventory loading by channel partners," indicating potential fraudulent practices [5]. Performance Disclosure - On August 19, 2025, James Hardie disclosed a 12% decline in sales in the North America Fiber Cement division, attributing it to the customer destocking previously denied [6]. - The CEO characterized the downturn as a "normalization of channel inventories," but warned of continued impacts on sales for at least the next two quarters [6]. Market Reaction - Following the disclosure of the decline, James Hardie's stock price fell by over 34%, leading to significant losses for investors [7]. - The lawsuit aims to recover damages for investors who suffered financial injuries due to the alleged wrongful acts during the class period [7]. Investigation by Hagens Berman - Hagens Berman is investigating the claims and is seeking information from investors who may have suffered losses or have knowledge relevant to the investigation [8].

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Stride, Inc. (NYSE: LRN) for potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit. Why Is Stride Being Investigated for Securities Fraud?Stride is an education technology company that provides an online platform to students thro ...

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating Varonis Systems, Inc. for potential violations of federal securities laws on behalf of investors who may have incurred losses [1] Investigation Details - The investigation is focused on Varonis Systems, Inc. following the release of its third quarter 2025 financial results on October 28, 2025 [1]

Core Viewpoint - Glancy Prongay & Murray LLP has initiated an investigation into Nidec Corporation regarding potential violations of federal securities laws, specifically targeting investors who may have incurred losses [1] Company Investigation - The investigation is focused on Nidec Corporation (OTC: NJDCY) and aims to assess the company's compliance with federal securities regulations [1] - Investors who have lost money on Nidec Corporation are encouraged to inquire about pursuing claims to recover their losses [1]

Core Viewpoint - A class action securities fraud lawsuit has been filed against KinderCare Learning Companies, Inc. to recover losses for investors affected by alleged fraudulent activities related to the company's initial public offering in October 2024 [2][3]. Group 1: Lawsuit Details - The lawsuit alleges that KinderCare made false statements and concealed incidents of child abuse, neglect, and harm at its facilities [3]. - It is claimed that KinderCare failed to provide the "highest quality care possible" and did not meet minimum standards in the child care industry, exposing the company to undisclosed risks of lawsuits and reputational damage [3]. Group 2: Investor Information - Investors who suffered losses in KinderCare stock during the relevant timeframe are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4]. - The lawsuit is on behalf of all purchasers of KinderCare common stock in or traceable to the company's October 2024 initial public offering [2]. Group 3: Legal Representation - Levi & Korsinsky LLP, a nationally recognized securities litigation firm, is representing the plaintiffs and has a strong track record in securing recoveries for shareholders [5].

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into potential securities fraud involving Netflix, Inc. and may file a class action on behalf of investors [1][3]. Group 1: Investigation Details - The investigation focuses on whether Netflix's board and officers failed to provide adequate oversight and disclosure regarding a significant tax dispute in Brazil [3]. - Following the release of its third-quarter earnings, Netflix's stock fell approximately 10% on October 22, 2025, due to a one-time $619 million tax charge related to the Brazilian legal dispute [3]. Group 2: Allegations and Concerns - Investors allege that Netflix's handling of the tax matter, including the timing and characterization of the expense, related disclosures, and the adequacy of board-level controls, raises questions about potential breaches of fiduciary duty and internal controls [3]. - The decline in stock price was attributed to the impact of the tax charge on the company's profit margins, despite otherwise strong growth [3].